NCT00849940

Brief Summary

The aim of this study is calibrate (adjust and tune) the CAS FORE-SIGHT Near-Infrared Spectroscopy (NIRS) monitor when used to measure the tissue oxygen saturation of internal organs (StO2). This is a measure of the amount of oxygen carried by the blood within the internal organs. In addition the study will assess the degree of similarities between StO2 and mean mixed venous oxygen saturation - a measure of the amount of oxygen carried in the blood returning to the heart.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2009

Completed
10 days until next milestone

Study Start

First participant enrolled

February 1, 2009

Completed
23 days until next milestone

First Posted

Study publicly available on registry

February 24, 2009

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

March 28, 2016

Completed
Last Updated

February 9, 2017

Status Verified

February 1, 2016

Enrollment Period

5.8 years

First QC Date

January 22, 2009

Results QC Date

November 9, 2015

Last Update Submit

December 20, 2016

Conditions

Keywords

SpectroscopyNear infraredOximetryHypoxemiaTissue oxygenationPediatric

Outcome Measures

Primary Outcomes (3)

  • Accuracy of NIRS Sensor to Estimate Flank Tissue Oxygen Saturation

    The flank tissue oxygen saturation (%) is determined from simultaneous arterial and venous blood samples processed through a blood gas machine. The blood oxygen saturation of the samples are entered into an equation to yield the best estimate of flank tissue oxygen saturation. This value is then compared to the NIRS oxygen saturation (%) displayed on the monitor. Accuracy is used to describe how close the NIRS oxygen saturation is to the flank tissue oxygen saturation. It can be expressed in terms of shots on target: bias (%) = how close are the shots to the bulls eye and precision (%) is how close are the shots to each other. oxygen saturation when measured displayed NIRS value of the tissue sensor placed over the flank to a reference CO-oximetry model, reported as bias and precision. The model is weighted as 30:70 arterial: central venous oxygen saturation when measured by blood gas co-oximetry.

    Data collected from individual participants over 4 hour timeframe.

  • Accuracy of NIRS Sensor to Estimate Intestine Tissue Oxygen Saturation

    The intestine tissue oxygen saturation (%) is determined from simultaneous arterial and venous blood samples processed through a blood gas machine. The blood oxygen saturation of the samples are entered into an equation to yield the best estimate of intestine tissue oxygen saturation. This value is then compared to the NIRS oxygen saturation (%) displayed on the monitor. Accuracy is used to describe how close the NIRS oxygen saturation is to the intestine tissue oxygen saturation. It can be expressed in terms of shots on target: bias (%) = how close are the shots to the bulls eye and precision (%) is how close are the shots to each other.

    Data collected from individual participants over 4 hour timeframe.

  • Accuracy of NIRS Sensor to Estimate Hepatic Tissue Oxygen Saturation

    The hepatic tissue oxygen saturation (%) is determined from simultaneous arterial and venous blood samples processed through a blood gas machine. The blood oxygen saturation of the samples are entered into an equation to yield the best estimate of hepatic tissue oxygen saturation. This value is then compared to the NIRS oxygen saturation (%) displayed on the monitor. Accuracy is used to describe how close the NIRS oxygen saturation is to the hepatic tissue oxygen saturation. It can be expressed in terms of shots on target: bias (%) = how close are the shots to the bulls eye and precision (%) is how close are the shots to each other.

    Data collected from individual participants over 4 hour timeframe.

Secondary Outcomes (2)

  • Correlation Between Somatic StO2 and Cerebral SctO2 Oxygen Saturation

    Data collected from individual participants over 4 hour timeframe

  • Correlation Between NIRS Derived Estimate of Hemoglobin Concentration and Measured Arterial Blood Hemoglobin Concentration.

    Data collected from individual participants over 4 hour timeframe

Study Arms (1)

CAS NIRS FORE-SIGHT oximeter

EXPERIMENTAL

Pediatric patients presenting for cardiac catheterization.

Device: CAS NIRS FORE-SIGHT oximeter

Interventions

Comparison of non-invasive tissue oxygen saturation with blood sample-derived (calculated) tissue oxygen saturation.

CAS NIRS FORE-SIGHT oximeter

Eligibility Criteria

AgeUp to 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • ≤ 18 years old
  • ≥ 2.5 kg and ≤ 40 kg weight
  • Undergoing cardiac catheterization at Duke pediatric cardiac catheterization laboratory

You may not qualify if:

  • Known structural neurologic or craniofacial disease
  • Arterial catheter placement not part of planned catheterization procedure
  • Anemia (hemoglobin \< 10 g/dl)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Health System

Durham, North Carolina, 27710, United States

Location

MeSH Terms

Conditions

Hypoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

Blood samples collected from pediatric patients undergoing cardiac catheterization. Venous blood samples taken from within IVC as close to the tissue of interest.

Results Point of Contact

Title
David MacLeod, M.B.
Organization
Duke University Medical Center

Study Officials

  • David B MacLeod, FCRA

    Duke Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2009

First Posted

February 24, 2009

Study Start

February 1, 2009

Primary Completion

November 1, 2014

Study Completion

November 1, 2014

Last Updated

February 9, 2017

Results First Posted

March 28, 2016

Record last verified: 2016-02

Locations